The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Processa Pharmaceuticals Inc’s current trading price is -81.43% away from its 52-week high, while its distance from the 52-week low is 130.98%. The stock’s price range for this period has been between $0.18 and $2.24 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.69 million for the day, a number notably lower than the average daily volume of 2.03 million over the last three months.
The present stock price for Processa Pharmaceuticals Inc (PCSA) is $0.42. In the last trading session, the stock made a considerable jump, reaching $0.45 after an opening price of $0.4198. The stock briefly fell to $0.4075 before ending the session at $0.39.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
In terms of market performance, Processa Pharmaceuticals Inc had a fairly uneven. The highest value for the stock in the past year was $2.24 on 12/15/22, and the lowest value was recorded at $0.18 on 10/06/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Processa Pharmaceuticals Inc (PCSA) has experienced a quarterly rise of 10.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 10.25M and boasts a workforce of 15 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3717, with a change in price of -0.0965. Similarly, Processa Pharmaceuticals Inc recorded 1,349,942 in trading volume during the last 100 days, posting a change of -18.83%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PCSA stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
PCSA Stock Stochastic Average
Processa Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 32.77%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 83.72%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 59.34% and 44.18%, respectively.
PCSA Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -62.18% this year. Over the last six months, there has been a stronger performance of -36.97%. The price of PCSA leaped by -23.82% during the last 30 days period. For the last 5-days stocks have improved 30.82%.
